 GERMANTOWN, Md., April 26, 2021 PRNewswire -- Seneca Biopharma, Inc. Nasdaq: SNCA Seneca or the Company, disclosed on April 23, 2021, the passing of the final proposal required for approval of the proposed merger between Seneca and Leading Biosciences, Inc. LBS. 